KawsarRasmyTalaatMD

Clinical Trials

• Single Group Study of the Safety of and Immune Response to a Bird Flu Vaccine (H7N3) in Healthy Adults Start of enrollment: 2007 Sep 01

  Completed

  Phase 1

• Safety of and Immune Response to Recombinant Live-Attenuated Influenza H6N1 Virus Vaccine Vaccine Start of enrollment: 2008 Sep 01

  Completed

  Phase 1

• Evaluating the Safety and Immune Response to an H5N1 Influenza Vaccine in People Who Have Previously Received an H5N1 or H7N3 Influenza Vaccine and in People Who Have Never Received a Live Attenuated Influenza Vaccine Start of enrollment: 2011 Oct 01

  Completed

  Phase 1

• Early Immune Responses to Inactivated Influenza Vaccine: a Pilot Study Start of enrollment: 2012 Jan 01

  Completed

  Not Applicable

• Evaluating the Safety and Immune Response to a Live H7N9 Influenza Virus Vaccine Followed by an Inactivated H7N9 Influenza Virus Vaccine, Given at Varying Intervals Start of enrollment: 2014 May 01

  Completed

  Phase 1

• Phase 2b Challenge Study With the Bioconjugate Vaccine Flexyn2a Start of enrollment: 2015 Dec 01

  Completed

  Phase 2

• Human Challenge Model Refinement With Enterotoxigenic Escherichia Coli Strain B7A Start of enrollment: 2016 Apr 01

  Completed

  Not Applicable

• Efficacy of B7A BSIgG Against E. Coli Strain B7A Challenge Start of enrollment: 2017 Jan 01

  Completed

  Phase 1

• Evaluating the Live-Attenuated Human Parainfluenza Virus Type 3 Vectored Vaccine Candidate Expressing Ebolavirus Zaire Glycoprotein as the Sole Envelope Glycoprotein Start of enrollment: 2018 Mar 05

  Suspended

  Phase 1

• Inpatient Challenge Study of rRSV A/Maryland/001/11, a Human Respiratory Syncytial Virus Challenge Strain, Administered to Healthy Adult Volunteers Start of enrollment: 2018 Jul 31

  Recruiting

  Phase 1

• Immunogenicity and Safety Study of Inactivated Subunit H5N1 Influenza Vaccine in Prior Recipients of Live Attenuated H2N2, H6N1 and H9N2 Influenza Vaccines and in H5N1 and Live Attenuated Vaccine Naïve Individuals Start of enrollment: 2019 Jan 08

  Completed

  Phase 1

• Controlled Human Infection Model Challenge/Rechallenge Start of enrollment: 2022 Apr 26

  Completed

  Phase 1

  Roles: Principal Investigator, Contact

• Phase I Safety Study of B/HPIV3/S-6P Vaccine Via Nasal Spray in Adults Start of enrollment: 2023 Sep 18

  Recruiting

  Phase 1

  Roles: Contact

• Pre-Study of Wild Type Enterotoxigenic E. Coli (ETEC) Strain for Verification of a Planned Challenge Dose Start of enrollment: 2024 Feb 12

  Recruiting

  Not Applicable

  Roles: Principal Investigator, Contact

• Join now to see all